A Call for the 113th Congress to Support an Innovation Agenda

greater American innovation or dampen development. Agencies should do more to regularly interact with the startup community and regional innovation organizations because their rich supply of talent can help educate federal agencies on the needs of startups. Congress should also require “Innovation Impact Statements” for all federal regulatory rulemakings.

Protect and extend America’s global edge in medical technology innovation by fully repealing the Medical Device Tax. Congress should fully repeal Obamacare’s misguided medical device tax, which taxes revenues—not profit—and is already hurting job creation and business expansion. The med-tech sector has been a consistent bright spot throughout the course of the weak economy. Med-tech innovation is critical to accomplishing the goals of healthcare reform—improving patient care while decreasing healthcare costs.

Foster improved STEM education, including workforce development partnerships. Congress should explore how best to unleash all 50 states to become laboratories of STEM improvement without excessive fear of running afoul of federal regulations.

Promote energy innovation to foster an environment to further propel clean tech advancements. Congress should advance innovative polices that create incentives for the clean energy sector, so startups and emerging companies are allowed to inject disruptive technologies into the marketplace in order to meet differing regional energy needs.

Strengthen intellectual property protections while fully funding the U.S. Patent and Trademark Office (USPTO) by providing full access to user fees. Congress and the Administration should continue their aggressive focus on strong U.S. intellectual property and trade secret protection; monitor the success and funding level of the USPTO. Past performance has shown that when USPTO has full access to its user fees, the patent application backlog decreases, and patent quality increases; and carefully monitor USPTO’s regulatory implementation of the America Invents Act paying particular attention to the new First to File regulations and the American Grace Period.

Various studies have indicated that tech startups are critical to driving job creation, economic growth, and U.S. competitiveness. These tech startups will migrate to wherever the business climate is best suited to foster their growth. The U.S. still holds many advantages over other countries for startup creation, but startup success is becoming increasingly difficult on a host of fronts. Plus, foreign competitors are passing laws to attract talent, R&D, and capital to their shores. Washington must quickly find solutions to these challenges so America will stay the home of startups and the land of opportunity.

The full innovation agenda is available online here.

 

Author: Duane J. Roth

In Memoriam: Our friend and Xconomist Duane Roth passed away on August 3, 2013, after a bicycle accident. We at Xconomy are deeply saddened by his loss. Duane J. Roth was Chief Executive Officer and member of the Board of CONNECT. CONNECT is the globally recognized public benefits organization fostering entrepreneurship in the San Diego region by catalyzing, accelerating, and supporting the growth of the most promising technology and life sciences innovation. Focused on assisting start-up companies in the San Diego region, CONNECT has been directly involved with over 1,500 companies since its inception in 1985. Prior to joining CONNECT, Mr. Roth founded Alliance Pharmaceutical Corp., where he served as Chief Executive Officer and Chairman of the Board. Prior to Alliance, Mr. Roth held senior management positions at Johnson & Johnson and Wyeth operating companies. He served as a member of the Board of Directors and executive committees of the Biotechnology Industry Organization (BIO), the California Healthcare Institute (CHI), BIOCOM (past Chair), Deep Sky Software Inc., and SAIC-Frederick, Inc. National Cancer Institute. Mr. Roth served on a number of advisory committees and boards of the University of California, including the President’s Board on Science and Innovation, the UCSD Sulpizio Cardiovascular Center (past Chair), the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, the Preuss Charter School (Chair), California Institute for Telecommunications and Information Technology (Calit2), the UC San Diego Foundation Board (past Chair), and UCSD Health Sciences Advisory Board. Mr. Roth was active in the San Diego community, serving on the board of the San Diego Regional Economic Development Corporation (past Chair), the San Diego Regional Chamber of Commerce, the Lincoln Club of San Diego (past Chair), the San Diego State University College of Business (past Chair), San Diego State University Sciences & Engineering Dean’s Advisory Board, as co-Chair of the Regional Housing Working Group, and a member of the Advisory Council for Math for America. Mr. Roth also served as a member of the Executive Board for the California State University (CSU) Professional Science Master’s (PSM) Programs. Mr. Roth was appointed to the Independent Citizens Oversight Committee for the California Institute of Regenerative Medicine (CIRM) by Governor Arnold Schwarzenegger and he also served as a member on the Governor’s Commission for Jobs and Economic Growth. Mr. Roth was a graduate of Iowa Wesleyan College, where he served as a trustee.